Stay updated on PSCA-Targeted CAR-T in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PSCA-Targeted CAR-T in Solid Tumors Clinical Trial page.

Latest updates to the PSCA-Targeted CAR-T in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed. This reflects an internal version update to the study record with no user-facing content changes indicated.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check54 days agoChange DetectedStatus updated to Terminated; sponsor information updated to Regeneron Pharmaceuticals with Bellicum as a former sponsor, and related dates and investigator fields adjusted.SummaryDifference1%

- Check68 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding–related operating status notice; no changes to the study details or data.SummaryDifference0.4%

- Check75 days agoChange DetectedThe study record now shows Results Submitted (replacing No Results Posted) with revision v3.4.1. A site-wide notice about a lapse in government funding was added.SummaryDifference0.5%

Stay in the know with updates to PSCA-Targeted CAR-T in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PSCA-Targeted CAR-T in Solid Tumors Clinical Trial page.